Qorvo announces that the U.S. Food and Drug Administration (FDA) has (EUA) for Rapid COVID-19 Antigen Testing at the Point of Care 

With this new approval, the shelf-life of the tests is now expanded to one year. According to iHealth Labs, this extension applies to existing test kits as well 

In some validation studies of these tests, like the one the FDA is conducting in Test: Assure COVID-19 IgG/IgM Rapid Test Device

This new FDA authorization allows an individual to perform the test themselves, without a doctor's prescription and at a lower cost. An Abbott spokesperson told ABC News the tests are expected to be sold in packs of two and will cost under $10 dollars per test. The spokesperson also said the test should be available in the coming weeks.

Roche announced Friday that the Food and Drug Administration has granted its at-home COVID-19 test emergency use authorization. The test, which uses a nasal swab sample, can produce "accurate,

NDC# 82607-0660-26. • NO PRESCRIPTION REQUIRED - AUTHORIZED under FDA EUA, for home use. • DETECTS ACTIVE COVID-19 INFECTION – Antigens indicate active disease, find out if you have COVID-19 by performing a painless nasal swab. • TEST ONCE, unlike other tests, no need to retest a couple of days after the 1st test, unless new symptoms

Here's a look at which at-home COVID tests the CDC says are approved by the FDA, and how long each of the kits are good for: BinaxNOW COVID-19 Ag Card Home Test, 15 months BinaxNOW COVID-19 Antigen

The FDA has authorized a number of at-home rapid antigen and polymerase chain reaction (PCR) COVID-19 tests, which are the two types of tests typically offered at official testing sites.

The Food and Drug Administration today granted full approval of Pfizer's COVID-19 vaccine for young teens, covering the age group spanning 12 to 

Aug 28,  · A new COVID-19 test will cost just $5. Getty Images. The FDA has given emergency approval to a new COVID-19 test that can give results in 15 minutes. The test is not as accurate as PCR tests that

Aug 27,  · But several companies are developing rapid at-home tests, though none have yet won FDA approval, the AP reported. Abbott's new test still requires a nasal swab be taken by a health worker, like